Amerika Serikat - Inggris - NLM (National Library of Medicine)

chartwell rx, llc - ipratropium bromide (unii: j697uz2a9j) (ipratropium - unii:gr88g0i6ul), albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - ipratropium bromide and albuterol sulfate inhalation solution is indicated for the treatment of bronchospasm associated with copd in patients requiring more than one bronchodilator. ipratropium bromide and albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components, or to atropine and its derivatives. follow these directions for use of your nebulizer / compressor or the directions given by your healthcare provider. a typical example is shown nearby. - remove one vial from the foil pouch. place remaining vials back into the pouch for storage. - twist the cap completely off the vial and squeeze the contents into the nebulizer reservoir (figure 1). 3. connect the nebulizer to the mouthpiece or face mask (figure 2). 4. connect the nebulizer to the compressor 5. sit in a comfortable, upright position; place the mouthpiece in your mouth (figure 3) or put on the face mask (figure 4); and turn on the compressor. 6. breathe as calmly, deeply and evenly as possible through your mouth until no more mist is formed in the nebulizer chamber (about 5 - 15 minutes). at this point, the treatment is finished. 7. clean the nebulizer (see manufacturer's instructions). l71928 revised: 01/2024

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

cipla (eu) limited - ipratropium bromide monohydrate ; salbutamol sulfate - nebuliser solution - 0.5mg/2.5 milligram - salbutamol and sodium cromoglicate

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - salbutamol sulfate -

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - salbutamol sulfate -

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

cipla europe nv - ipratropium bromide monohydrate; salbutamol sulfate - nebuliser solution - 0.5mg/2.5 milligram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salbutamol and sodium cromoglicate

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

rex medical ltd - ipratropium bromide monohydrate 0.021mg equivalent to ipratropium bromide anhydrous 0.020 mg;  ; salbutamol sulfate 0.12mg equivalent to salbutamol 0.100 mg - aerosol inhaler, metered dose - 0.02mg/0.1mg per dose - active: ipratropium bromide monohydrate 0.021mg equivalent to ipratropium bromide anhydrous 0.020 mg   salbutamol sulfate 0.12mg equivalent to salbutamol 0.100 mg excipient: heptafluoropropane lactose monohydrate - duolin hfa is indicated for the treatment of reversible bronchospasm associated with obstructive airway diseases in patients who require more than a single bronchodilator.

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

norton healthcare limited t/a ivax pharmaceuticals uk - ipratropium bromide - nebuliser solution - 250 microgram/ml - ipratropium bromide

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - salbutamol sulfate -

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - salbutamol sulfate, quantity: 3 mg (equivalent: salbutamol, qty 2.5 mg) - inhalation, conventional - excipient ingredients: water for injections; sulfuric acid; sodium chloride - for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise induced asthma or in other situations known to induce bronchospasm.

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

azure pharmaceuticals ltd - ipratropium bromide monohydrate; salbutamol sulfate - nebuliser solution - 0.5mg/2.5 milligram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salbutamol and sodium cromoglicate